Vabysmo (faricimab-svoa intravitreal injection) — Medica
Neovascular (wet) age-related macular degeneration
Initial criteria
- Administered by or under the supervision of an ophthalmologist
Reauthorization criteria
- Administered by or under the supervision of an ophthalmologist
Approval duration
1 year